It reduces lipogenesis, the process of creating new fat
Community protocols on TRT describe: BPC-157: 250-500 mcg subcutaneous, 1-2x daily (near the injury site when possible) TB-500: 2-5 mg subcutaneous, 2x per week (loading), then 2 mg weekly (maintenance) Stacking both for 4-8 weeks for injury recovery No cycling described used as needed during recovery periods For the detailed breakdown, see our BPC-157 dosing guide, TB-500 dosing guide, and the BPC-157 vs TB-500 comparison
Pathological models demonstrate that ROS-driven mechanisms are involved in reproductive disorders
Down 30 lbs and counting
however, it does significantly reduce the percentage of skin cells with significant melanin content (score 3)
The nuclei were counterstained with DAPI and covered with ProLong Gold antifade reagent with DAPI (Life Technologies Corporation, OR, United States)